| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |